Atheronova, Inc. (fka AHROQ)

[LarryW]

AtheroNova is developing products that will regress atherosclerotic plaque deposits. The plaque on artery walls that results in heart attacks and strokes will be dissolved, fully or partially, by these natural compounds, if all goes well. For that to happen, approval must be secured from the Food and Drug Administration after successful research, development and testing. AtheroNova (AHRO) has the management team in place that can make that happen through experience, not hope. Investors should take note. This has been demonstrated by the successful results of a recent test at the University of California Los Angeles,
http://www.smallcapnetwork.com/AtheroNova-has-Management-Team-needed-for-Success-AHRO-PFE-AZN/s/via/3420/article/view/p/mid/1/id/416/

LW